Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Pilot Study to Test the Role of Medium- and Long-chain Triacylglycerols (MLCT) in Reversing the Phenotype of Non-alcoholic Steatohepatitis (NASH) Patients

NCT05217745 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT05217745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05217745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Pilot Study to Test the Role of Medium- and Long-chain Triacylglycerols (MLCT) in Reversing the Phenotype of Non-alcoholic Steatohepatitis (NASH) Patients
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Unknown status
Start date
August 5, 2021
Completion date
March 31, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis